Clinical Trial Update: Exceptional Experiences (EE), Salience & Dopaminergic Neurotransmission [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial completed at the University of Zurich exploring exceptional experiences, salience, and dopaminergic neurotransmission in healthy individu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizotypal Personality Disorder

Snippet

Sponsor: University of Zurich | Conditions: Healthy, Schizotypal Personality | EARLY_Phase 1 | Status: COMPLETED